Deep Learning and Random Forest Approach for Finding the Optimal Traditional Chinese Medicine Formula for Treatment of Alzheimer's Disease
- PMID: 30888812
- DOI: 10.1021/acs.jcim.9b00041
Deep Learning and Random Forest Approach for Finding the Optimal Traditional Chinese Medicine Formula for Treatment of Alzheimer's Disease
Abstract
It has demonstrated that glycogen synthase kinase 3β (GSK3β) is related to Alzheimer's disease (AD). On the basis of the world largest traditional Chinese medicine (TCM) database, a network-pharmacology-based approach was utilized to investigate TCM candidates that can dock well with multiple targets. Support vector machine (SVM) and multiple linear regression (MLR) methods were utilized to obtain predicted models. In particular, the deep learning method and the random forest (RF) algorithm were adopted. We achieved R2 values of 0.927 on the training set and 0.862 on the test set with deep learning and 0.869 on the training set and 0.890 on the test set with RF. Besides, comparative molecular similarity indices analysis (CoMSIA) was performed to get a predicted model. All of the training models achieved good results on the test set. The stability of GSK3β protein-ligand complexes was evaluated using 100 ns of MD simulation. Methyl 3- O-feruloylquinate and cynanogenin A induced both more compactness to the GSK3β complex and stable conditions at all simulation times, and the GSK3β complex also had no substantial fluctuations after a simulation time of 5 ns. For TCM molecules, we used the trained models to calculate predicted bioactivity values, and the optimum TCM candidates were obtained by ranking the predicted values. The results showed that methyl 3- O-feruloylquinate contained in Phellodendron amurense and cynanogenin A contained in Cynanchum atratum are capable of forming stable interactions with GSK3β.
Similar articles
-
Insight into potent leads for alzheimer's disease by using several artificial intelligence algorithms.Biomed Pharmacother. 2020 Sep;129:110360. doi: 10.1016/j.biopha.2020.110360. Epub 2020 Jun 16. Biomed Pharmacother. 2020. PMID: 32559623
-
In silico investigation of traditional Chinese medicine compounds to inhibit human histone deacetylase 2 for patients with Alzheimer's disease.Biomed Res Int. 2014;2014:769867. doi: 10.1155/2014/769867. Epub 2014 Jun 23. Biomed Res Int. 2014. PMID: 25045700 Free PMC article.
-
Artificial Intelligence Approach to Find Lead Compounds for Treating Tumors.J Phys Chem Lett. 2019 Aug 1;10(15):4382-4400. doi: 10.1021/acs.jpclett.9b01426. Epub 2019 Jul 22. J Phys Chem Lett. 2019. PMID: 31304749
-
GSK3beta signalling: casting a wide net in Alzheimer's disease.Neurosignals. 2002 Sep-Oct;11(5):251-61. doi: 10.1159/000067423. Neurosignals. 2002. PMID: 12566926 Review.
-
Neurogenic Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer's Disease.Int J Mol Sci. 2017 Jan 28;18(2):272. doi: 10.3390/ijms18020272. Int J Mol Sci. 2017. PMID: 28134846 Free PMC article. Review.
Cited by
-
Quantification of Cognitive Function in Alzheimer's Disease Based on Deep Learning.Front Neurosci. 2021 Mar 17;15:651920. doi: 10.3389/fnins.2021.651920. eCollection 2021. Front Neurosci. 2021. PMID: 33815051 Free PMC article.
-
Identifying Synergistic Mechanisms of Multiple Ingredients in Shuangbai Tablets against Proteinuria by Virtual Screening and a Network Pharmacology Approach.Evid Based Complement Alternat Med. 2020 Jan 6;2020:1027271. doi: 10.1155/2020/1027271. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32025234 Free PMC article.
-
A focus on harnessing big data and artificial intelligence: revolutionizing drug discovery from traditional Chinese medicine sources.Chem Sci. 2023 Sep 26;14(39):10628-10630. doi: 10.1039/d3sc90185h. eCollection 2023 Oct 11. Chem Sci. 2023. PMID: 37829008 Free PMC article.
-
A bioinformatics investigation into the pharmacological mechanisms of the effect of the Yinchenhao decoction on hepatitis C based on network pharmacology.BMC Complement Med Ther. 2020 Feb 12;20(1):50. doi: 10.1186/s12906-020-2823-y. BMC Complement Med Ther. 2020. PMID: 32050950 Free PMC article.
-
Investigating the Molecular Mechanism of Quercetin Protecting against Podocyte Injury to Attenuate Diabetic Nephropathy through Network Pharmacology, MicroarrayData Analysis, and Molecular Docking.Evid Based Complement Alternat Med. 2022 May 16;2022:7291434. doi: 10.1155/2022/7291434. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35615688 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
